Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2025-12-24 @ 7:02 PM
NCT ID:
NCT03058757
Eligibility Criteria:
Inclusion Criteria:
* The subjects who will undergo transurethral resection of the tumor after diagnosis of bladder cancer
* Male or female aged 18 or over 18 years and not more than 85 years who were diagnosed as bladder cancer
* Normal bone marrow function: Hemoglobin \>10 g/dL, ANC \>1,500/mm3, platelet count\>100,000/mm3
* Normal renal function: serum creatinine ≤ 1.4 mg/dL
* Normal liver function:
* Bilirubin ≤ 1.5 times of upper normal limit
* AST/ALT ≤ 1.8 times of upper normal limit
* Alkaline phosphatase ≤ 1.8 times of upper normal limit
* Subjects who voluntarily decided to participate and signed the written informed consent
Exclusion Criteria:
* Non-urothelial carcinoma
* Muscle invasive bladder cancer
* Subjects who underwent intravesical mitomycin-C instillation after diagnosis of bladder cancer within 3 years
* Prior hypersensitivity reaction history to mitomycin-C
* Neurogenic bladder
* Subjects who underwent chemotherapy due to any cancer within 6 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
84 Years
Study:
NCT03058757
Study Brief:
Protocol Section:
NCT03058757